SARS-COV-2 vaccination

Intervention

2 papers3 findings

  • 2 independent labs in 2 countries
  • Funders: National Natural Science Foundation of China and 3 more
  • Humans2

Associations

3

High anti-SARS-CoV-2 antibody levels

upin humans1OR 4.36

1 study
  1. SARS-COV-2 vaccination is associated with high anti-SARS-CoV-2 antibody levels in humans (OR 4.36).

    “Receiving ≥ 3 vaccine doses was associated with high antibody levels (OR: 4.36, p = 0.001)”

    Humansserum≥ 3 vaccine dosesn = 93

    PhenoAge acceleration predicts antibody persistence and breakthrough infection after SARS-CoV-2 vaccination and infection

    Journal of infection and public health10 Oct 2025

More on High anti-SARS-CoV-2 antibody levels

Neutralizing antibody production

upin humans1

1 study
  1. SARS-COV-2 vaccination is associated with neutralizing antibody production in humans.

    “vaccination improved cTfh-cm, cTfh2, cTfr proportion and promoted NAb production.”

    HumansCOVID-19

    Age-dependent decrease of circulating T follicular helper cells correlates with disease severity in elderly patients with COVID-19

    Clinical immunology (Orlando, Fla.)25 Jul 2024

More on Neutralizing antibody production

cTfh-cm, cTfh2 and cTfr proportions

upin humans1

1 study
  1. SARS-COV-2 vaccination is associated with cTfh-cm, cTfh2 and cTfr proportions in humans.

    “vaccination improved cTfh-cm, cTfh2, cTfr proportion and promoted NAb production.”

    HumansCOVID-19

    Age-dependent decrease of circulating T follicular helper cells correlates with disease severity in elderly patients with COVID-19

    Clinical immunology (Orlando, Fla.)25 Jul 2024

More on cTfh-cm, cTfh2 and cTfr proportions

Latest